Table 2.
Patients’ demographics and clinical characteristics. FUSCC 2006–18 (n = 48)
| Variable | FUSCC validation cohort | |
|---|---|---|
| No. | % | |
| Total | 48 | 100.00 |
| Race | ||
| Othersa | 48 | 100.00 |
| Age | ||
| 18–39 | 6 | 12.50 |
| 40–59 | 24 | 50.00 |
| >60 | 18 | 37.50 |
| Sex | ||
| Female | 24 | 50.00 |
| Male | 24 | 50.00 |
| T | ||
| T1 | 0 | 0.00 |
| T2 | 4 | 8.33 |
| T3 | 19 | 39.58 |
| T4 | 25 | 52.08 |
| N | ||
| N0 | 14 | 29.17 |
| N1 | 21 | 43.75 |
| N2 | 13 | 27.08 |
| M | ||
| M1a | 27 | 56.25 |
| M1b | 21 | 43.75 |
| CEA | ||
| Negative | 3 | 6.25 |
| Positive | 45 | 93.75 |
| Grade | ||
| Well/Moderately differentiated | 32 | 66.67 |
| Poorly differentiated/Undifferentiated | 16 | 33.33 |
| Histology | ||
| Adenocarcinoma | 39 | 81.25 |
| Mucinous adenocarcinoma | 9 | 18.75 |
| Signet ring cell carcinoma | 0 | 0.00 |
aAll patients are Chinese.